CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancerRaymond J. Lim, Bin Liu, Jensen Abascal et al.|Cell Reports Medicine|2024Cited by 111
Abstract 4208: <i>In situ</i> vaccination of non-small cell lung cancer with CXCL9/10-engineered dendritic cells combined with PD-1 blockadeRaymond J. Lim, Steven M. Dubinett, Ramin Salehi‐Rad et al.|Cancer Research|2022Cited by 1